Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Beijing Biostar Pharmaceuticals Co., Ltd. Proxy Solicitation & Information Statement 2025

May 2, 2025

50675_rns_2025-05-02_157f9fcb-2c36-4e50-ba71-86042f2b1cf0.pdf

Proxy Solicitation & Information Statement

Open in viewer

Opens in your device viewer

华昊中天

Biostar

Beijing Biostar Pharmaceuticals Co., Ltd.

北京華昊中天生物醫藥股份有限公司

(A joint stock company incorporated in the People's Republic of China with limited liability)

(Stock code: 2563)

FORM OF PROXY FOR USE AT THE EXTRAORDINARY GENERAL MEETING TO BE HELD ON FRIDAY, 23 MAY 2025

I/We (Name)

(Block capitals) of (Address)

being the holder(s) of (see Note 1) shares of RMB1.00 each

in the share capital of Beijing Biostar Pharmaceuticals Co., Ltd. (the "Company") hereby appoint (Name)

of (Address)

and (Email Address)

of

failing him/her, (Name)

of (Address)

and (Email Address)

or failing him/her, the chairman of the meeting (see Note 2) as my/our proxy to attend and vote for me/us and on my/our behalf at the extraordinary general meeting (the "EGM") of the Company to be held virtually using online platform at http://meetings.computershare.com/biostar20250523 (the "Online Platform") on Friday, 23 May 2025 at 10:00 a.m. and at any adjournment thereof or on any resolution or motion which is proposed thereat. My/Our proxy is authorised and instructed to vote as indicated (see Note 3) in respect of the undermentioned resolutions:

Ordinary Resolutions For Against
1. To consider and approve the proposed by-election of Independent Non-Executive Director.
2. To consider and approve the proposed by-election of Non-Executive Director.
3. To consider and approve the proposed application for Full Circulation of unlisted shares of the Company.
4. To consider and approve the proposed grant of authorization to the Board of Directors and its delegated persons to handle matters related to the application for Full Circulation of unlisted shares of the Company.
5. To consider and approve the proposed appointment of new auditors: (i) appoint Daxin Global (Hong Kong) Certified Public Accountants Ltd. as the new auditor of the Company; (ii) the auditors' fee for the new auditor shall be RMB1.65 million; and (iii) authorise the Directors to execute all such documents, instruments and agreements and do all such acts or things to give effect to the above appointment of new auditors and matters connected therewith.
Special Resolution (see Note 3) For Against
6. To consider and approve the proposed amendments to the Articles of Association.

Dated this __ day of, __ 2025

Signature(s) _____ (see Note 5)

Notes:

  1. Please insert the number of shares registered in your name(s); if no number is inserted, this form of proxy will be deemed to relate to all the shares in the capital of the Company registered in your name(s).
  2. A member may appoint more than one proxy of his/her own choice if the member is the holder of two or more shares. If such an appointment is made, strike out the words "the chairman of the meeting", and insert the name(s) of the person(s) appointed as proxy in space provided. Any alteration made to this form of proxy must be initialed by the person who signs it.
  3. IMPORTANT: IF YOU WISH TO VOTE FOR ANY RESOLUTION, PLEASE TICK THE BOX MARKED "For". IF YOU WISH TO VOTE AGAINST ANY RESOLUTION, PLEASE TICK THE BOX MARKED "Against". Failure to tick a box will entitle your proxy to cast your vote at his/her discretion. Your proxy will also be entitled to vote at his/her discretion on any resolution properly put to the meeting other than those referred to in the notice convening the meeting.
  4. If the holder is a corporation, this form must be under common seal or under the hand of an officer or attorney duly authorised on that behalf.
  5. In the case of joint holders, all holders should sign on the proxy form and the names of all the joint holders should be stated.

Where there are joint holders of any share of the Company, any one of such joint holders may vote at the meeting, either in person or by proxy, in respect of such share as if he/she were solely entitled thereto, but if more than one of such joint holders be present at the meeting, the vote of the senior who tenders a vote, whether in person or by proxy, will be accepted to the exclusion of the votes of the other joint holders, and for this purpose seniority shall be determined as that one of the said persons so present whose name stands first on the register of members in respect of such share shall alone be entitled to vote in respect thereof.

  1. In order to be valid, a proxy form and the power of attorney or other authority (if any) under which it is signed, or a notarially certified copy of such power of attorney, must be deposited at the Company's H share registrar in Hong Kong, Computershare Hong Kong Investor Services Limited at 17M Floor, Hopewell Centre, 183 Queen's Road East, Wanchai, Hong Kong, not less than 24 hours before the time fixed for holding the meeting or any adjournment thereof. Completion and delivery of this proxy form will not preclude you from attending and voting at the meeting if you so wish.
  2. A proxy need not be a member of the Company.